271 related articles for article (PubMed ID: 34905511)
1. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
Humeres C; Shinde AV; Hanna A; Alex L; Hernández SC; Li R; Chen B; Conway SJ; Frangogiannis NG
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905511
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart.
Humeres C; Shinde AV; Tuleta I; Hernandez SC; Hanna A; Huang S; Venugopal H; Aguilan JT; Conway SJ; Sidoli S; Frangogiannis NG
Circ Res; 2024 Jun; ():. PubMed ID: 38899461
[TBL] [Abstract][Full Text] [Related]
3. The role of endogenous Smad7 in regulating macrophage phenotype following myocardial infarction.
Li J; Li R; Tuleta I; Hernandez SC; Humeres C; Hanna A; Chen B; Frangogiannis NG
FASEB J; 2022 Jul; 36(7):e22400. PubMed ID: 35695814
[TBL] [Abstract][Full Text] [Related]
4. Smad-dependent pathways in the infarcted and failing heart.
Humeres C; Venugopal H; Frangogiannis NG
Curr Opin Pharmacol; 2022 Jun; 64():102207. PubMed ID: 35367786
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart.
Huang S; Chen B; Su Y; Alex L; Humeres C; Shinde AV; Conway SJ; Frangogiannis NG
J Mol Cell Cardiol; 2019 Jul; 132():84-97. PubMed ID: 31085202
[TBL] [Abstract][Full Text] [Related]
6. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
[TBL] [Abstract][Full Text] [Related]
7. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
8. Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium.
Kong P; Shinde AV; Su Y; Russo I; Chen B; Saxena A; Conway SJ; Graff JM; Frangogiannis NG
Circulation; 2018 Feb; 137(7):707-724. PubMed ID: 29229611
[TBL] [Abstract][Full Text] [Related]
9. Adrenomedullin Ameliorates Pulmonary Fibrosis by Regulating TGF-ß-Smads Signaling and Myofibroblast Differentiation.
Wei Y; Tanaka M; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Cui N; Kakihara S; Zhao Y; Aruga K; Sanjo H; Shindo T
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33955458
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
Alex L; Tuleta I; Hernandez SC; Hanna A; Venugopal H; Astorkia M; Humeres C; Kubota A; Su K; Zheng D; Frangogiannis NG
Circulation; 2023 Sep; 148(11):882-898. PubMed ID: 37350296
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.
Shukla MN; Rose JL; Ray R; Lathrop KL; Ray A; Ray P
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):643-53. PubMed ID: 18988920
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of smad7 inhibits the TGF-β/Smad signaling pathway and EMT in NPHP1-defective MDCK cells.
Wu X; Wang H; Chen H; Lin H; Li M; Yue Z; Sun L
Biochem Biophys Res Commun; 2021 Dec; 582():57-63. PubMed ID: 34689106
[TBL] [Abstract][Full Text] [Related]
14. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
17. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
18. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.
Li JH; Zhu HJ; Huang XR; Lai KN; Johnson RJ; Lan HY
J Am Soc Nephrol; 2002 Jun; 13(6):1464-72. PubMed ID: 12039975
[TBL] [Abstract][Full Text] [Related]
19. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.
Saxena A; Shinde AV; Haque Z; Wu YJ; Chen W; Su Y; Frangogiannis NG
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):223-31. PubMed ID: 26542797
[TBL] [Abstract][Full Text] [Related]
20. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction.
Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z
Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
